EKG

iRhythm Technologies Announces First Quarter 2024 Financial Results

Retrieved on: 
星期四, 五月 2, 2024
EKG, ACC, HRS, IRTC, Traction, Growth, Patient, Heart failure, SAN, Interest, Pharmaceutical industry

SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024.

Key Points: 
  • SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024.
  • Revenue for the first quarter of 2024 was $131.9 million, up 18.4% from $111.4 million during the same period in 2023.
  • Operating expenses for the first quarter of 2024 were $125.7 million, compared to $115.2 million for the same period in 2023.
  • Adjusted operating expenses for the first quarter of 2024 were $125.7 million, compared to $109.5 million during the same period in 2023.

o9 Expands Its Collaboration With Microsoft to Advance Generative AI Capabilities in the o9 Digital Brain Planning Platform With Microsoft Azure OpenAI Service

Retrieved on: 
星期二, 四月 16, 2024
Data Management, Technology, Logistics, Supply Chain Management, Transport, Software, Networks, Artificial Intelligence, Knowledge, Corporation, EKG, AI, OpenAI, LLM, RAG, API, REST, Digital, Automation, Microsoft, Word, Microsoft Outlook, Enterprise, Organization, Microsoft PowerPoint, Online shopping

o9 , a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that it is expanding its collaboration with Microsoft by integrating Microsoft Azure OpenAI Service applications with the o9 Digital Brain to improve the platform’s AI-powered planning capabilities.

Key Points: 
  • o9 , a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that it is expanding its collaboration with Microsoft by integrating Microsoft Azure OpenAI Service applications with the o9 Digital Brain to improve the platform’s AI-powered planning capabilities.
  • Azure OpenAI Service provides REST API access to OpenAI's powerful large language models (LLM), including the GPT-4, GPT-3.5-Turbo, and Embeddings model series.
  • “We are pleased to strengthen our long-standing collaboration with o9 to make generative AI capabilities accessible to more companies.
  • By integrating Microsoft Azure OpenAI Service into the AI-powered o9 Digital Brain platform, we can help manufacturers turn their data into action, allowing for faster decision-making and optimized planning,” said Dominik Wee, Corporate Vice President of Manufacturing & Mobility at Microsoft.

o9 Reports 36% Annual Recurring Revenue Growth

Retrieved on: 
星期三, 四月 10, 2024
Technology, Transport, Software, Networks, Logistics, Supply Chain Management, Retail, Data Management, Artificial Intelligence, Knowledge, EKG, Telecommunications, Generative, Enterprise, Synthetic media, ARR, O9, Growth, Tourism

o9 , a leading enterprise AI software platform provider for transforming planning and decision-making, today reported that its annual recurring revenue (ARR) in Q1’24 grew 36% year-over-year.

Key Points: 
  • o9 , a leading enterprise AI software platform provider for transforming planning and decision-making, today reported that its annual recurring revenue (ARR) in Q1’24 grew 36% year-over-year.
  • During the quarter, o9 participated in the 54th annual Davos World Economic Forum 2024 in Davos, Switzerland, where it hosted an exclusive executive panel.
  • In March, the Company successfully organized its annual client event, aim10x digital 2024 , to transform supply chain and commercial planning.
  • Chakri Gottemukkala, Co-founder and CEO of o9, said, “o9 is committed to delivering unparalleled value to our customers by transforming their business planning and decision-making capabilities.

Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It

Retrieved on: 
星期日, 四月 7, 2024
Health, Sports, Football, Other Health, Other Science, Research, Science, Blood pressure, TTE, FACC, African Americans, Prevalence, Aortic stenosis, National Football League, Patient, Education, Ageing, Journal, History, MD, City, Male, American College, TAVR, EKG, AFL, Interventional cardiology, Alumni association, NFL, National Football League Alumni, Hypertension, Pharmaceutical industry

Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families.
  • Results of the HUDDLE study indicated that the prevalence of hypertension in the 498 screened participants was 83.8%, though only about half (46.5%) self-reported a history of hypertension.
  • Conducted across eight U.S. cities in cooperation with NFL Alumni Health, a subsidiary of the NFL Alumni Association, HUDDLE was a cross sectional study of NFL alumni and their family members aged 50 years and above.
  • Study participants self-reported their medical histories and participated in heart health education and screenings that included blood pressure, electrocardiogram (EKG) and echocardiogram.

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

Retrieved on: 
星期四, 三月 14, 2024
Diagnosis, Hayashi, DPN, Diabetes, Patient, Dunker, Polyneuropathy, EKG

WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy (DPN).

Key Points: 
  • WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy (DPN).
  • The reference standard for DPN was a gold standard nerve conduction study.
  • DPNCheck combined with CVR-R had high diagnostic performance with an area under the receiver operating curve of 0.88.
  • The authors concluded "The use of DPNCheck and electrocardiogram would make the diagnosis of DPN simple, ubiquitous, and with high reproducibility and reliability."

o9 Transforms Integrated Planning and Decisioning With GenAI-Powered Innovations to Its Digital Brain Platform

Retrieved on: 
星期四, 四月 4, 2024
Retail, Data Management, Energy, Manufacturing, Technology, Professional Services, Supply Chain Management, Artificial Intelligence, General Automotive, Transport, Other Manufacturing, Automotive, Software, Logistics, Other Energy, Data Analytics, Knowledge, Synthetic media, Arasu, AI, Enterprise, Organization, EKG, Generative, Sales

o9’s trailblazing Digital Brain platform with its EKG model at the core had strong AI roots from the very inception.

Key Points: 
  • o9’s trailblazing Digital Brain platform with its EKG model at the core had strong AI roots from the very inception.
  • It has driven significant value by bringing siloes across supply chain, finance, and sales onto a single collaborative planning platform.
  • Chakri Gottemukkala, o9 Co-Founder and CEO, said, “The AI roots of our Digital Brain platform give us a significant edge in the usage of GenAI.
  • While our Digital Brain platform was transformative in the scope of integrated planning, there were some constraints limiting the level of knowledge being ingested and modeled in the EKG.

Global Medical Adhesives & Sealants Market Report 2024 - Wide Array of Solutions and Application Areas Offered by Soft-Skin Adhesives Facilitating Market Growth - ResearchAndMarkets.com

Retrieved on: 
星期一, 四月 1, 2024
Medical Supplies, Health, Blood pressure, Adhesive, Dentistry, Growth, Prevalence, Vital signs, Patient, Conditional sentence, Radiation, Palliative care, Metal, Bacteria, Instrument, Electrode, Fibrin, Chronic radiation syndrome, Skin, Collagen, EKG, USB On-The-Go, Cosmetics, Acrylic

The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Adhesives & Sealants Market - Resin Types, Applications and End-use Sectors" report has been added to ResearchAndMarkets.com's offering.
  • The growth in demand for soft-skin adhesives has been made possible by the wide variety of their applications in the medical, pharmaceutical and personal care areas.
  • Soft-skin adhesives find application in a range of medical areas, which comprise skin therapies, wound dressing and wearable medical devices, providing further impetus to demand for them.
  • The range of applications for adhesives and sealants the medical sector includes the areas of dentistry & cosmetics, internal & external surgery and medical devices & equipment.

Anthem Blue Cross and Blue Shield Partners with Care2U and Independent Practice Association of New York, Inc. to Avoid Hospitalizations Through Advanced Care at Home Program

Retrieved on: 
星期一, 三月 25, 2024
Insurance, Hospitals, Telemedicine, Virtual Medicine, Professional Services, Health Insurance, Practice Management, Other Health, Managed Care, General Health, Health, RN, Elevance Health, Risk, Patient, IPA, MD, New Yorker, Blue Shield, Anatomical pathology, EKG, Hospital, Nursing

Anthem Blue Cross and Blue Shield in New York (formerly Empire BlueCross BlueShield) recently honored Care2U and Independent Practice Association of New York (IPA NY), part of Vytalize Health, with the inaugural Anthem Blue Cross and Blue Shield Innovation in Healthcare Award for the organizations’ work to improve health outcomes through its new High-Intensity Physician-Led Advanced Care at Home (HIPLACH) program.

Key Points: 
  • Anthem Blue Cross and Blue Shield in New York (formerly Empire BlueCross BlueShield) recently honored Care2U and Independent Practice Association of New York (IPA NY), part of Vytalize Health, with the inaugural Anthem Blue Cross and Blue Shield Innovation in Healthcare Award for the organizations’ work to improve health outcomes through its new High-Intensity Physician-Led Advanced Care at Home (HIPLACH) program.
  • This innovative collaboration provides state-of-the-art care in the home by a treating Care2U physician and other clinicians for members with acute conditions that would otherwise require inpatient hospitalization.
  • The program focuses on improving the quality of care, enhancing the patient experience, and lowering overall costs.
  • “IPA NY and Care2U have been the ideal partners to help us achieve our mission of improving the health of New Yorkers.

Proem Introduces 'Touchless' Mental Health Care Workflow

Retrieved on: 
星期三, 四月 3, 2024
Diagnosis, Depression, Organization, Letter, Arrhythmia, Patient, Preface, Triage, Anxiety, Workflow, Pediatrics, Workload, EHR, EKG, Obstetrics, Health, ECG, Nursing

ATLANTA, April 3, 2024 /PRNewswire-PRWeb/ -- Proem Behavioral Health, developer of evidence-based mental health assessment and measurement technology, is pleased to announce a new software version that provides a touchless workflow experience for clinicians and staff. The new release makes it easy for health care providers – including those in primary care, pediatrics, obstetrics, federally qualified health centers, and behavioral health and addiction clinics – to screen, assess, diagnose and track patients who suffer from mental illness.

Key Points: 
  • ATLANTA, April 3, 2024 /PRNewswire-PRWeb/ -- Proem Behavioral Health, developer of evidence-based mental health assessment and measurement technology, is pleased to announce a new software version that provides a touchless workflow experience for clinicians and staff.
  • The new release makes it easy for health care providers – including those in primary care, pediatrics, obstetrics, federally qualified health centers, and behavioral health and addiction clinics – to screen, assess, diagnose and track patients who suffer from mental illness.
  • "As the mental health crisis in America grows, patients are increasingly seeking behavioral health services from their primary care and other physical medicine providers due to convenience, comfort and reduced stigma," explains Proem CEO John Letter.
  • "Our latest platform update reflects our mission to simplify the mental health care journey for providers and patients.

Care2U Honored by Anthem Blue Cross and Blue Shield with Inaugural Innovation in Healthcare Award for Advancing Care in the Home

Retrieved on: 
星期三, 三月 27, 2024
RN, Health, Organization, Patient, Independent practice association, IPA, Elevance Health, New Yorker, Blue Shield, Anatomical pathology, EKG, Hospital, Nursing

NEW YORK, March 27, 2024 /PRNewswire/ -- Today, Care2U is proud to announce that they have been recognized, along with Independent Practice Association of New York (IPA NY), part of Vytalize Health, with the inaugural Anthem Blue Cross and Blue Shield Innovation in Healthcare Award for their transformative work to improve health outcomes through their new High-Intensity Physician-Led Advanced Care at Home (HIPLACH) program.

Key Points: 
  • Through HIPLACH, the organizations offer Hospital-Level care in the home, that would ordinarily require in-patient hospitalization.
  • The program focuses on improving the quality of care, enhancing patient experience, and lowering overall costs.
  • "We are proud to honor these leaders with the first Anthem Blue Cross and Blue Shield Innovation in Healthcare Award for their pioneering efforts to provide the highest quality care for our members," said Daniel Kassan, MD, director of medical operations for Anthem Blue Cross and Blue Shield in New York.
  • "IPA NY and Care2U have been the ideal partners to help us achieve our mission of improving the health of New Yorkers.